Advanced Filters
noise
Found 1,274 clinical trials
P Peter H Kahn, Prof.

Benefits of Outdoor Walks in Reducing Depressive Symptoms

The goal of this clinical trial is to determine whether outdoor walking in different environments-urban or natural-can reduce depressive symptoms among college students. The study also tests whether providing prompts for active engagement during nature walks enhances the benefits compared to unstructured nature walks. Participants will be randomly assigned to …

18 years of age All Phase N/A
N Niki Antypa, PhD

BioClock: Bright Light Therapy for Depressive Disorders

Bright Light Therapy (BLT) is a proven treatment for depression in seasonal and non-seasonal depressive disorders, as well as bipolar disorder. To make BLT more effective and practical in clinical settings and tailor it to individual needs, it is necessary to optimize the treatment approach, understand how the treatment works, …

18 - 65 years of age All Phase N/A

Digital Cognitive Behavioral Therapy for Depressive Disorders

This study aims to explore the effectiveness of digital interventions combined with medication in the treatment of patients with depressive disorders. Its main aim is to answer: Can digital interventions combined with medication effectively alleviate symptoms of depression? The experiment will compare the effects of medication combined with digital interventions …

18 - 65 years of age All Phase N/A
A Andrea Giannelli

Online or In-person Interventions on Anxiety and Depression Symptoms in Caregivers of Patients with Cancer

Oncological diseases are considered a family disease because when one member is diagnosed with cancer, the psycho-physical, social and economic consequences affect the entire family. In Italy, approximately 17% of the population assists a family member. These caregivers are typically unpaid individuals such as partners, offspring, and relatives who provide …

18 years of age All Phase N/A
S Silvana Nader

Efficacy of Statins Among Major Depressive Disorder

The goal of this clinical trial is to learn if drug Rosuvastatin 10 mg works to treat MDD in adults. It will also learn about the safety of Rosuvastatin 10 mg .The main questions it aims to answer are: Does Rusovastatin lower the score of The Montgomery Asberg Depression Rating …

20 - 45 years of age All Phase 3
K Kangguang Lin, MD, Ph.D

TDCS Interventions for Subthreshold Depressive Symptoms in Young Individuals.

The purpose of this study is to assess the mechanisms of the effect of transcranial direct current stimulation (tDCS) in alleviating subthreshold depressive symptoms in young individuals, and individualized outcome prediction is carried out.

12 - 25 years of age All Phase N/A
R Roxanne Hoks Research Program Manager, BA

Well-being Training for Adolescent Depressive Symptoms (TeenWell Study)

This study is being done to see if the Healthy Minds Program app helps adolescents with elevated depressive symptoms. Up to 200 participants will be on study for 20 weeks.

14 - 19 years of age All Phase N/A
A Alina Moosburner

The Effect of Mediterranean Diet and Mindfulness Eating on Depression Severity in People With Obesity and Major Depressive Disorder

The present study investigates the effect of Mediterranean Diet and Mindful Eating on depression severity in people with obesity and major depressive disorder. The factorial design allows to investigate potential synergistic effects of the interventions. Participants will be randomized to one of the four intervention groups (mediterranean diet, mindful eating, …

18 years of age All Phase N/A
E EMBRACE Team

A Randomized Neuroimaging Trial of Psilocybin in Depression

The goal of this neuroimaging clinical trial is to test whether psilocybin produces significant immediate changes in functional brain activity in networks associated with mood regulation and depression compared to placebo in patients with depression. The trial aims to determine if psilocybin: Changes connectivity within brain networks associated with mood …

18 - 64 years of age All Phase 2
T Trial Manager

Home-Based tDCS Treatment Of Major Depressive Disorder

The REACH-tDCS study will evaluate the safety and efficacy of a noninvasive, at-home self-administered Sooma tDCS brain stimulation treatment for Major Depressive Disorder. The study uses randomized, blinded, placebo controlled design. The participants are assessed with video interviews and self-reports during the study, which lasts for 10 weeks followed by …

22 - 70 years of age All Phase N/A

Simplify language using AI